Cargando…

Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors

Recurrent pericarditis (RP) is a complex inflammatory disorder associated with adverse outcomes and poor quality of life. After the first episode of acute pericarditis, a non‐negligible group of patients will fail to achieve complete remission despite treatment and will be challenged by side effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo Presti, Saberio, Elajami, Tarec K., Reyaldeen, Reza, Anthony, Chris, Imazio, Massimo, Klein, Allan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Contemporary Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649126/ https://www.ncbi.nlm.nih.gov/pubmed/34569270 http://dx.doi.org/10.1161/JAHA.121.021685

Ejemplares similares

Multimodality imaging in the diagnosis and management of prosthetic valve endocarditis: A contemporary narrative review
por: Lo Presti, Saberio, et al.
Publicado: (2021)

Case report. Thrombus formation on left atrial appendage clip: surgical exclusion and anticoagulation do not obviate transesophageal echocardiography prior to cardioversion
por: Lo Presti, Saberio, et al.
Publicado: (2022)

Anti-interleukin-1 agents for pericarditis: a primer for cardiologists( )
por: Imazio, Massimo, et al.
Publicado: (2021)

More Than a Simple Vegetation: The Trifecta of Mitral Valve Leaflet Perforation, Windsock Aneurysm, and Mitral Valve Abscess
por: Reyaldeen, Reza, et al.
Publicado: (2020)

Recurrent pericarditis: an update on diagnosis and management
por: Andreis, Alessandro, et al.
Publicado: (2021)

Inflamed Colon and Pericardium: A Rare Combination of Colitis and Recurrent Pericarditis
por: Kumar, Ashwin K., et al.
Publicado: (2021)

Transthoracic versus intra-operative transesophageal echocardiography in right heart assessment
por: Lo Presti, Saberio, et al.
Publicado: (2020)

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023)

Targeting inflammatory citokines to prevent constriction in tuberculous pericarditis and beyond?
por: Imazio, Massimo
Publicado: (2018)

Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY
por: Brucato, Antonio, et al.
Publicado: (2022)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Quantitative assessment of pericardial delayed hyperenhancement helps identify patients with ongoing recurrences of pericarditis
por: Kumar, Arnav, et al.
Publicado: (2018)

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis
por: Markel, Gal, et al.
Publicado: (2016)

The Emerging Role of Irisin in Cardiovascular Diseases
por: Fu, Jinjuan, et al.
Publicado: (2021)

Cardiovascular Diseases That Have Emerged From the Darkness
por: Maron, Barry J., et al.
Publicado: (2021)

Assessment of the Opportunities for Pharmaceutical Manufacturers in Emerging Markets
por: Anderson, Tim, et al.
Publicado: (2009)

Value of cardiovascular magnetic resonance in patients with suspected inflammatory pericarditis
por: Cruz, Inês, et al.
Publicado: (2015)

Emerging Arrhythmic Risk of Autoimmune and Inflammatory Cardiac Channelopathies
por: Lazzerini, Pietro Enea, et al.
Publicado: (2018)

How do nurses better predict outcomes for adult COVID-19 patients receiving nasal high flow therapy in the emergency care setting?
por: ODonnell, Jane, et al.
Publicado: (2021)

Refractory Recurrent Pericarditis After Pericardiectomy in a Young Woman
por: Lak, Hassan Mehmood, et al.
Publicado: (2021)

Therapeutic Challenges and Emerging Treatment Targets for Pulmonary Hypertension in Left Heart Disease
por: Lteif, Christelle, et al.
Publicado: (2021)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

SGLT‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects
por: Lam, Carolyn S. P., et al.
Publicado: (2019)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
por: Handelsman, Yehuda, et al.
Publicado: (2018)

Natriuretic peptides to differentiate constrictive pericarditis and restrictive cardiomyopathy: A systematic review and meta‐analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2021)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Fingerprinting MINOCA: Unraveling Clues With Quantitative CMR
por: Lo Presti, Saberio, et al.
Publicado: (2023)

Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure
por: Packer, Milton
Publicado: (2020)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Effects on the Cost and Utilization of Proton Pump Inhibitors From Adding Over-the Counter Omeprazole to Drug Benefit Coverage in a State Employee Health Plan
por: Harris, Brittany N., et al.
Publicado: (2004)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis
por: Punch, Emily, et al.
Publicado: (2022)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis
por: Klein, Benjamin M., et al.
Publicado: (2022)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

The Endothelium Abridges Insulin Resistance to Premature Aging
por: Avogaro, Angelo, et al.
Publicado: (2013)

Insights Into Aortic Sclerosis and Its Relationship With Coronary Artery Disease
por: Milin, Alexandra C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k7sc10k5en9ub6injbo9tm616a